Cooper Companies, Inc. (The) (COO) Shares Bought by Prudential Financial Inc.

Prudential Financial Inc. boosted its stake in shares of Cooper Companies, Inc. (The) (NYSE:COO) by 3.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 68,652 shares of the medical device company’s stock after buying an additional 2,174 shares during the period. Prudential Financial Inc. owned 0.14% of Cooper Companies, Inc. (The) worth $13,723,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Generation Investment Management LLP boosted its position in Cooper Companies, Inc. (The) by 70.8% in the third quarter. Generation Investment Management LLP now owns 232,608 shares of the medical device company’s stock valued at $41,697,000 after buying an additional 96,448 shares during the period. Dynamic Capital Management Ltd boosted its position in shares of Cooper Companies, Inc. (The) by 199.7% in the third quarter. Dynamic Capital Management Ltd now owns 15,866 shares of the medical device company’s stock valued at $2,844,000 after buying an additional 10,572 shares during the period. Gotham Asset Management LLC purchased a new position in shares of Cooper Companies, Inc. (The) during the third quarter valued at about $2,570,000. Robecosam AG boosted its position in shares of Cooper Companies, Inc. (The) by 50.0% in the third quarter. Robecosam AG now owns 1,200 shares of the medical device company’s stock valued at $211,000 after buying an additional 400 shares during the period. Finally, Pioneer Investment Management Inc. purchased a new position in shares of Cooper Companies, Inc. (The) during the third quarter valued at about $33,715,000. 98.31% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Cooper Companies, Inc. (NYSE:COO) traded up 0.04% during trading on Friday, reaching $239.94. The company’s stock had a trading volume of 117,266 shares. The stock has a market cap of $11.72 billion, a P/E ratio of 35.97 and a beta of 0.56. The company’s 50 day moving average price is $218.54 and its 200-day moving average price is $195.05. Cooper Companies, Inc. has a 1-year low of $158.73 and a 1-year high of $243.89.

Cooper Companies, Inc. (The) (NYSE:COO) last announced its earnings results on Thursday, June 1st. The medical device company reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.25 by $0.25. Cooper Companies, Inc. (The) had a return on equity of 15.88% and a net margin of 16.02%. The firm had revenue of $522.40 million for the quarter, compared to the consensus estimate of $520.71 million. During the same quarter in the previous year, the business earned $2.05 EPS. The company’s revenue was up 8.0% compared to the same quarter last year. Equities analysts forecast that Cooper Companies, Inc. will post $9.61 earnings per share for the current fiscal year.

WARNING: This story was originally posted by BBNS and is the property of of BBNS. If you are reading this story on another site, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://baseballnewssource.com/markets/prudential-financial-inc-has-13-72-million-stake-in-cooper-companies-inc-coo-updated/962379.html.

A number of research analysts have recently commented on COO shares. Piper Jaffray Companies reissued an “overweight” rating and set a $220.00 price target on shares of Cooper Companies, Inc. (The) in a report on Thursday, April 6th. J P Morgan Chase & Co reiterated a “neutral” rating and issued a $206.00 price target (up previously from $200.00) on shares of Cooper Companies, Inc. (The) in a research report on Monday, June 5th. Jefferies Group LLC restated a “buy” rating and set a $250.00 price objective (up from $220.00) on shares of Cooper Companies, Inc. (The) in a research report on Saturday, June 3rd. Zacks Investment Research upgraded Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $226.00 price target for the company in a report on Wednesday, May 3rd. Finally, BMO Capital Markets reissued a “buy” rating on shares of Cooper Companies, Inc. (The) in a research note on Friday, March 3rd. Two equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Cooper Companies, Inc. (The) has an average rating of “Buy” and a consensus target price of $230.44.

In other Cooper Companies, Inc. (The) news, CEO Paul L. Remmell sold 3,605 shares of the business’s stock in a transaction on Tuesday, April 4th. The shares were sold at an average price of $199.99, for a total transaction of $720,963.95. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Carol R. Kaufman sold 44,092 shares of the business’s stock in a transaction on Thursday, June 8th. The shares were sold at an average price of $242.81, for a total transaction of $10,705,978.52. Following the sale, the executive vice president now directly owns 60,419 shares in the company, valued at approximately $14,670,337.39. The disclosure for this sale can be found here. In the last quarter, insiders sold 59,292 shares of company stock worth $14,006,145. 1.60% of the stock is owned by company insiders.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with our FREE daily email newsletter.

 


Latest News

Hitters in Major League Baseball on Record Home Run Pace
Hitters in Major League Baseball on Record Home Run Pace
Atlanta Considering Playing Freddie Freeman at Third
Atlanta Considering Playing Freddie Freeman at Third
Injury to Gleyber Torres Adds to Questions About Yankees
Injury to Gleyber Torres Adds to Questions About Yankees
Game Winning Home Run Completes Nolan Arenado Cycle
Game Winning Home Run Completes Nolan Arenado Cycle
New York Yankees and Masahiro Tanaka Hit Hard Again
New York Yankees and Masahiro Tanaka Hit Hard Again
Victor Martinez Diagnosed with Irregular Heartbeat
Victor Martinez Diagnosed with Irregular Heartbeat


Leave a Reply

 
© 2006-2017 BBNS.